Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.97 USD | +6.93% |
|
+9.01% | +15.62% |
Jun. 25 | Oppenheimer Initiates Keros Therapeutics at Outperform With $102 Price Target | MT |
Jun. 18 | Keros Therapeutics Names Chief Executive Officer Jasbir Seehra as Board Chair | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEROS THERAPEUTICS, INC. | Bio Therapeutic Drugs | +6.93% | +9.01% | +15.62% | +18.30% | - | 1.55B | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- KROS Stock
- Charts Keros Therapeutics, Inc.
- Relative Strength Chart